NIH Ditches Funding for Research Using Aborted Fetal Tissue Amid Trump-Era Ban
The National Institutes of Health (NIH) announced Thursday that it will no longer fund research using human fetal tissue obtained from "elective" abortions, marking a significant shift in the agency's stance on biomedical research.
The move comes as part of a broader effort by the Trump administration to end research involving fetal tissue from abortions. The ban is the latest attempt to restrict this type of research, which has been a point of contention for anti-abortion advocates for years.
Under President Biden, who reversed some of his predecessor's policies on fetal tissue research in 2021, the NIH had resumed funding projects using such tissue. However, the agency's new policy takes a hard line against it.
"The decision to deauthorize research that uses human fetal tissue is about advancing science and investing in breakthrough technologies," said Jay Bhattacharya, the NIH director. "This aligns with our commitment to reflecting the best science of today and the values of the American people."
The ban applies to all NIH-funded projects involving fetal tissue from abortions, but researchers can still use tissue from miscarriages. However, this type of tissue is often deemed unsuitable for research due to its abnormal composition.
Fetal tissue has played a crucial role in advancing research into various diseases, including diabetes, Alzheimer's, and infertility. It has also contributed significantly to the development and production of vaccines against polio, hepatitis A, rabies, and other illnesses.
According to the NIH, the number of agency-backed projects involving fetal tissue from abortions has been declining since 2019, when the Trump administration first implemented this policy. In fiscal year 2024, the organization directed almost $60 million to 77 projects that used such tissue.
The National Institutes of Health (NIH) announced Thursday that it will no longer fund research using human fetal tissue obtained from "elective" abortions, marking a significant shift in the agency's stance on biomedical research.
The move comes as part of a broader effort by the Trump administration to end research involving fetal tissue from abortions. The ban is the latest attempt to restrict this type of research, which has been a point of contention for anti-abortion advocates for years.
Under President Biden, who reversed some of his predecessor's policies on fetal tissue research in 2021, the NIH had resumed funding projects using such tissue. However, the agency's new policy takes a hard line against it.
"The decision to deauthorize research that uses human fetal tissue is about advancing science and investing in breakthrough technologies," said Jay Bhattacharya, the NIH director. "This aligns with our commitment to reflecting the best science of today and the values of the American people."
The ban applies to all NIH-funded projects involving fetal tissue from abortions, but researchers can still use tissue from miscarriages. However, this type of tissue is often deemed unsuitable for research due to its abnormal composition.
Fetal tissue has played a crucial role in advancing research into various diseases, including diabetes, Alzheimer's, and infertility. It has also contributed significantly to the development and production of vaccines against polio, hepatitis A, rabies, and other illnesses.
According to the NIH, the number of agency-backed projects involving fetal tissue from abortions has been declining since 2019, when the Trump administration first implemented this policy. In fiscal year 2024, the organization directed almost $60 million to 77 projects that used such tissue.